Severe COVID-19 | Gut bacteria and blood vessels | Hairy skin

Cancer drug may reduce symptoms of severe COVID-19; gut bacteria and abnormal blood vessel formation; hairy human skin from stem cells

June 16, 2020 Edition COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can find the latest public health information from CDC at www.coronavirus.gov and the latest research information from NIH at www.nih.gov/coronavirus. Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics. Cancer drug may reduce symptoms of severe COVID-19 In patients with COVID-19, off-label use of a cancer drug reduced respiratory distress and over-reactive immune responses. The results were used to inform the design of a clinical trial Gut bacteria may contribute to abnormal blood vessel formation People with abnormal clusters of blood vessels in the brain called cavernous angiomas had differences in their gut bacteria. The findings could help lead to new diagnostic tests and treatments. Hairy human skin generated from stem cells Researchers created hair-growing skin from human stem cells and successfully grafted it to mice. Popular Stories Novel coronavirus structure reveals targets for vaccines and treatments Llama antibody engineered to block coronavirus Study suggests new coronavirus may remain on surfaces for days Beneficial bacteria prevent recurring bacterial vaginosis How stress causes gray hair Connect with Us Facebook RSS Feed Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®      This email was sent to ymilov@gmail.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612